Cargando…
Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476102/ https://www.ncbi.nlm.nih.gov/pubmed/22143739 http://dx.doi.org/10.4317/medoral.17628 |
_version_ | 1782247046087966720 |
---|---|
author | Sancho-Puchades, Manuel Vílchez-Pérez, Miguel A. Valmaseda-Castellón, Eduard Paredes-García, Jordi Berini-Aytés, Leonardo Gay-Escoda, Cosme |
author_facet | Sancho-Puchades, Manuel Vílchez-Pérez, Miguel A. Valmaseda-Castellón, Eduard Paredes-García, Jordi Berini-Aytés, Leonardo Gay-Escoda, Cosme |
author_sort | Sancho-Puchades, Manuel |
collection | PubMed |
description | Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative efficacy. Statistical significant lower pain levels were observed with bupivacaine between the fifth (p=0.011) and the ninth (p=0.007) postoperative hours. Bupivacaine provided significantly longer lasting soft tissue anesthesia (p<0.05). Systolic blood pressure and heart rate values were significantly higher with articaine. Conclusions: Bupivacaine could be a valid alternative to articaine especially due to its early postoperative pain prevention ability. Key words:Bupivacaine, articaine, third molar, anesthesia, postoperative pain. |
format | Online Article Text |
id | pubmed-3476102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medicina Oral S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-34761022012-10-19 Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial Sancho-Puchades, Manuel Vílchez-Pérez, Miguel A. Valmaseda-Castellón, Eduard Paredes-García, Jordi Berini-Aytés, Leonardo Gay-Escoda, Cosme Med Oral Patol Oral Cir Bucal Research-Article Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative efficacy. Statistical significant lower pain levels were observed with bupivacaine between the fifth (p=0.011) and the ninth (p=0.007) postoperative hours. Bupivacaine provided significantly longer lasting soft tissue anesthesia (p<0.05). Systolic blood pressure and heart rate values were significantly higher with articaine. Conclusions: Bupivacaine could be a valid alternative to articaine especially due to its early postoperative pain prevention ability. Key words:Bupivacaine, articaine, third molar, anesthesia, postoperative pain. Medicina Oral S.L. 2012-05 2011-12-06 /pmc/articles/PMC3476102/ /pubmed/22143739 http://dx.doi.org/10.4317/medoral.17628 Text en Copyright: © 2012 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research-Article Sancho-Puchades, Manuel Vílchez-Pérez, Miguel A. Valmaseda-Castellón, Eduard Paredes-García, Jordi Berini-Aytés, Leonardo Gay-Escoda, Cosme Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial |
title | Bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. A crossover randomized controlled trial |
title_full | Bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. A crossover randomized controlled trial |
title_fullStr | Bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. A crossover randomized controlled trial |
title_full_unstemmed | Bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. A crossover randomized controlled trial |
title_short | Bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. A crossover randomized controlled trial |
title_sort | bupivacaine 0.5 % versus articaine 4 % for the removal of lower
third molars. a crossover randomized controlled trial |
topic | Research-Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476102/ https://www.ncbi.nlm.nih.gov/pubmed/22143739 http://dx.doi.org/10.4317/medoral.17628 |
work_keys_str_mv | AT sanchopuchadesmanuel bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial AT vilchezperezmiguela bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial AT valmasedacastelloneduard bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial AT paredesgarciajordi bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial AT beriniaytesleonardo bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial AT gayescodacosme bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial |